Evvy
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Evvy - overview
Established
2020
Location
New York, NY, US
Primary Industry
Biotechnology
About
Based in New York, US, and founded in 2020, Allora Health Inc. doing business as Evvy operates as a female technology company focusing on women's health. The company was co-founded by CEO Priyanka Jain and CMO Laine Bruzek. In July 2021, Evvy raised USD 5 million in Seed funding from General Catalyst, Box Group, Virtue, Human Ventures, G9 Ventures, and BBG Ventures.
Evvy offers a vaginal microbiome test leveraging metagenomic sequencing to demystify Yeast Infections, BV, Chronic UTIs, the vaginal microbiome, and overall female health. The company provides a personalized wellness plan after the vaginal microbiome test. The test results are delivered back after 2 weeks in a personal private online dashboard with the actionable results. Evvy also offers flags research that linking imbalances in the vaginal microbiome to more serious issues like infertility or pre-term birth that even linkages to the progression of cervical cancer.
Evvy generates revenue on a commercial service paying by its users. Evvy plans to expand into new biomarkers and datasets. The company sells a kit that is not medically p approved. The company plans to pursue FDA clearance in the future.
Current Investors
General Catalyst Partners, BoxGroup, BBG Ventures
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Monitoring Equipment
Website
www.evvy.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.